相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ebola virus (EBOV) infection: Therapeutic strategies
Erik De Clercq
BIOCHEMICAL PHARMACOLOGY (2015)
Hydroxychloroquine and Chloroquine Retinopathy A Systematic Review Evaluating the Multifocal Electroretinogram as a Screening Test
Adrian C. Tsang et al.
OPHTHALMOLOGY (2015)
Influence of quinacrine and chloroquine on the in vitro 3′-azido-3′-deoxythymidine antiretroviral effect
Klintsy J. Torres et al.
AIDS RESEARCH AND THERAPY (2015)
Evaluation of Ebola Virus Inhibitors for Drug Repurposing
Peter B. Madrid et al.
ACS INFECTIOUS DISEASES (2015)
Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy
J-P Routy et al.
HIV MEDICINE (2015)
Lack of Protection Against Ebola Virus from Chloroquine in Mice and Hamsters
Darryl Falzarano et al.
EMERGING INFECTIOUS DISEASES (2015)
Transient Increase of Interferon-Stimulated Genes and No Clinical Benefit by Chloroquine Treatment During Acute Simian Immunodeficiency Virus Infection of Macaques
Monica Vaccari et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2014)
Modulation of HIV-1-Induced Activation of Plasmacytoid Dendritic Cells by 6-Desfluoroquinolones
Caroline M. Royle et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2014)
Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
Adriaan H. de Wilde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Ruxolitinib and Tofacitinib Are Potent and Selective Inhibitors of HIV-1 Replication and Virus Reactivation In Vitro
Christina Gavegnano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?
A. Saez-Cirion et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2014)
Plasmodium infection reduces the volume of the viral reservoir in SIV-infected rhesus macaques receiving antiretroviral therapy
Xiao-Yong Zhan et al.
RETROVIROLOGY (2014)
Persistent immune activation in chronic HIV infection: do any interventions work?
Reena Rajasuriar et al.
AIDS (2013)
Microbial Translocation in the Pathogenesis of HIV Infection and AIDS
Giulia Marchetti et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
HIV-associated chronic immune activation
Mirko Paiardini et al.
IMMUNOLOGICAL REVIEWS (2013)
Immune activation and HIV persistence: implications for curative approaches to HIV infection
Nichole R. Klatt et al.
IMMUNOLOGICAL REVIEWS (2013)
Hydroxychloroquine preferentially induces apoptosis of CD45RO+ effector T cells by inhibiting autophagy: A possible mechanism for therapeutic modulation of T cells
Jorg van Loosdregt et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents
Peter B. Madrid et al.
PLOS ONE (2013)
Investigational treatment suspension and enhanced cell-mediated immunity at rebound followed by drug-free remission of simian AIDS
Iart Luca Shytaj et al.
RETROVIROLOGY (2013)
A candidate anti-HIV reservoir compound, auranofin, exerts a selective 'anti-memory' effect by exploiting the baseline oxidative status of lymphocytes
B. Chirullo et al.
CELL DEATH & DISEASE (2013)
Immune activation and HIV persistence: considerations for novel therapeutic interventions
Hiroyu Hatano
CURRENT OPINION IN HIV AND AIDS (2013)
Inhibitory effects of chloroquine on the activation of plasmacytoid dendritic cells in SIVmac239-infected Chinese rhesus macaques
Jian-Ping Ma et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2012)
Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
Liang Shan et al.
IMMUNITY (2012)
Effects of Hydroxychloroquine on Immune Activation and Disease Progression Among HIV-Infected Patients Not Receiving Antiretroviral Therapy A Randomized Controlled Trial
Nicholas I. Paton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Gold drug auranofin restricts the viral reservoir in the monkey AIDS model and induces containment of viral load following ART suspension
Mark G. Lewis et al.
AIDS (2011)
Biomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection
Gregor F. Lichtfuss et al.
BIOMARKERS IN MEDICINE (2011)
Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders
Stefania Piconi et al.
BLOOD (2011)
Low levels of SIV infection in sooty mangabey central memory CD4+ T cells are associated with limited CCR5 expression
Mirko Paiardini et al.
NATURE MEDICINE (2011)
Maintenance of CD4(+) T-cell memory and HIV persistence: keeping memory, keeping HIV
Nicolas Chomont et al.
CURRENT OPINION IN HIV AND AIDS (2011)
Short Communication: Preferential Concentration of Hydroxychloroquine in Adenoid Tissue of HIV-Infected Subjects
Lucinda Aguirre-Cruz et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2010)
Chloroquine Modulates HIV-1-Induced Plasmacytoid Dendritic Cell Alpha Interferon: Implication for T-Cell Activation
Jeffrey A. Martinson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Reduction of Immune Activation with Chloroquine Therapy during Chronic HIV Infection
Shannon M. Murray et al.
JOURNAL OF VIROLOGY (2010)
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
Nicolas Chomont et al.
NATURE MEDICINE (2009)
Modeling Latently Infected Cell Activation: Viral and Latent Reservoir Persistence, and Viral Blips in HIV-infected Patients on Potent Therapy
Libin Rong et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
Impaired restoration of plasmacytoid dendritic cells in HIV-1-infected patients with poor CD4 T cell reconstitution is associated with decrease in capacity to produce IFN-α but not proinflammatory cytokines
Naresh Sachdeva et al.
JOURNAL OF IMMUNOLOGY (2008)
Relationship between T cell activation and CD4(+) T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy
Peter W. Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Llama Antibody Fragments with Cross-Subtype Human Immunodeficiency Virus Type 1 (HIV-1)-Neutralizing Properties and High Affinity for HIV-1 gp120
Anna Forsman et al.
JOURNAL OF VIROLOGY (2008)
Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections
Judith N. Mandl et al.
NATURE MEDICINE (2008)
Effect of chloroquine on reducing HIV-I replication in vitro and the DC-SIGN mediated transfer of virus to CD4+ T-lymphocytes
Marloes A. Naarding et al.
RETROVIROLOGY (2007)
Auranofin, as an anti-rheumatic gold compound, suppresses LPS-induced homodimerization of TLR4
Hyung S. Youn et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Quinoline antimalarials as investigational drugs for HIV-1/AIDS: In vitro effects on HIV-1 replication, HIV-1 response to antiretroviral drugs, and intracellular antiretroviral drug concentrations
Andrea Savarino et al.
DRUG DEVELOPMENT RESEARCH (2006)
Endocytosis of HIV-1 activates plasmacytoid dendritic cells via toll-like receptor-viral RNA interactions
AS Beignon et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks
NI Paton et al.
HIV MEDICINE (2005)
Immune activation set point during early FHV infection predicts subsequent CD4+ T-cell changes independent of viral load
SG Deeks et al.
BLOOD (2004)
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy
PW Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis
T Munster et al.
ARTHRITIS AND RHEUMATISM (2002)
Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1
NI Paton et al.
LANCET (2002)
Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity
A Savarino et al.
AIDS (2001)
The potential place of chloroquine in the treatment of HIV-1-infected patients
JR Boelaert et al.
JOURNAL OF CLINICAL VIROLOGY (2001)
Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs
M Vezmar et al.
BIOCHEMICAL PHARMACOLOGY (2000)
分享论文
